Notice: This company has been marked as potentially delisted and may not be actively trading. OmniLit Acquisition (OLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends OLIT vs. BNGO, ASTC, PRPO, TLIS, TBIO, SPEC, THMO, OLITW, PRENW, and QSIAWShould you be buying OmniLit Acquisition stock or one of its competitors? The main competitors of OmniLit Acquisition include Bionano Genomics (BNGO), Astrotech (ASTC), Precipio (PRPO), Talis Biomedical (TLIS), Telesis Bio (TBIO), Spectaire (SPEC), ThermoGenesis (THMO), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), and Quantum-Si (QSIAW). These companies are all part of the "measuring and control equipment" industry. OmniLit Acquisition vs. Bionano Genomics Astrotech Precipio Talis Biomedical Telesis Bio Spectaire ThermoGenesis OmniLit Acquisition Prenetics Global Quantum-Si Bionano Genomics (NASDAQ:BNGO) and OmniLit Acquisition (NASDAQ:OLIT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, community ranking, institutional ownership and dividends. Do insiders and institutionals believe in BNGO or OLIT? 11.4% of Bionano Genomics shares are owned by institutional investors. Comparatively, 21.6% of OmniLit Acquisition shares are owned by institutional investors. 1.4% of Bionano Genomics shares are owned by insiders. Comparatively, 78.0% of OmniLit Acquisition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to BNGO or OLIT? In the previous week, Bionano Genomics had 7 more articles in the media than OmniLit Acquisition. MarketBeat recorded 7 mentions for Bionano Genomics and 0 mentions for OmniLit Acquisition. OmniLit Acquisition's average media sentiment score of 0.00 beat Bionano Genomics' score of -0.01 indicating that OmniLit Acquisition is being referred to more favorably in the news media. Company Overall Sentiment Bionano Genomics Neutral OmniLit Acquisition Neutral Is BNGO or OLIT more profitable? OmniLit Acquisition has a net margin of 0.00% compared to Bionano Genomics' net margin of -407.34%. OmniLit Acquisition's return on equity of 0.00% beat Bionano Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Bionano Genomics-407.34% -154.45% -80.78% OmniLit Acquisition N/A N/A N/A Do analysts prefer BNGO or OLIT? Bionano Genomics presently has a consensus target price of $1.50, suggesting a potential upside of 631.35%. Given Bionano Genomics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Bionano Genomics is more favorable than OmniLit Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bionano Genomics 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00OmniLit Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, BNGO or OLIT? Bionano Genomics has a beta of 2.37, indicating that its share price is 137% more volatile than the S&P 500. Comparatively, OmniLit Acquisition has a beta of 0.05, indicating that its share price is 95% less volatile than the S&P 500. Does the MarketBeat Community believe in BNGO or OLIT? Bionano Genomics received 162 more outperform votes than OmniLit Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformBionano GenomicsOutperform Votes16264.03% Underperform Votes9135.97% OmniLit AcquisitionN/AN/A Which has better earnings & valuation, BNGO or OLIT? OmniLit Acquisition has lower revenue, but higher earnings than Bionano Genomics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBionano Genomics$36.12M0.58-$232.49M-$2.32-0.09OmniLit AcquisitionN/AN/AN/AN/AN/A SummaryBionano Genomics and OmniLit Acquisition tied by winning 6 of the 12 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get OmniLit Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for OLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OLIT vs. The Competition Export to ExcelMetricOmniLit AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$5.49M$271.24M$108.29M$8.79BDividend YieldN/A7.57%5.20%4.07%P/E RatioN/A2.161.0714.02Price / SalesN/A146.641.2087.41Price / CashN/A80.91100.1736.27Price / BookN/A73.36519.866.33Net IncomeN/A$32.24M$2.82M$225.71M OmniLit Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OLITOmniLit AcquisitionN/A$0.89-2.2%N/A-89.1%$5.49MN/A0.003Gap UpBNGOBionano Genomics1.3815 of 5 stars$0.21-2.1%$1.50+631.4%-85.7%$20.92M$36.12M0.00300ASTCAstrotech0.9272 of 5 stars$7.45+3.2%N/A-3.3%$12.67M$1.66M0.0010PRPOPrecipio1.2245 of 5 stars$6.03+0.5%N/A-15.8%$8.92M$15.20M0.0060Positive NewsGap DownTLISTalis BiomedicalN/A$1.69-1.4%N/A-76.1%$3.08M$2.13M0.00260TBIOTelesis BioN/A$0.90-5.3%N/A-86.5%$1.60M$27.51M0.00200Gap DownSPECSpectaireN/A$0.05+7.8%N/A-97.8%$893,000.00N/A0.008Gap UpTHMOThermoGenesisN/A$0.00flatN/A-100.0%$4,000.00$9.44M0.0025OLITWOmniLit AcquisitionN/A$0.04-20.0%N/A-49.9%$0.00N/A0.003Gap DownPRENWPrenetics GlobalN/A$0.01flatN/A+0.0%$0.00$22.66M0.001QSIAWQuantum-SiN/A$0.12+1.7%N/A-52.0%$0.00$1.70M0.00159High Trading Volume Related Companies and Tools Related Companies BNGO Alternatives ASTC Alternatives PRPO Alternatives TLIS Alternatives TBIO Alternatives SPEC Alternatives THMO Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OLIT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OmniLit Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OmniLit Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
